# Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

> **NCT01890902** · PHASE3 · WITHDRAWN · sponsor: **Imprimis Pharmaceuticals, Inc.**

## Conditions studied

- Acute Pain (Flare) Associated With Osteoarthritis (OA) of the Knee

## Interventions

- **DRUG:** Ketoprofen 10% Cream
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01890902
- **Lead sponsor:** Imprimis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-08
- **Primary completion:** 2014-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890902, "Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01890902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*